When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works.

Microsoft outs crucial Windows 11 beta build 22000.348 to patch Kaspersky compatibility bug

windows 11 inside preview written next to a virtual laptop running Windows 11

Microsoft today has released a new Windows 11 build for Insiders on the Beta and the Release Preview channels. The latest build 22000.348 (KB5007262) brings a small but very important fix related to Kaspersky whereupon certain Windows updates were causing issues and preventing the Kaspersky apps from upgrading properly. Other than that, the new build carries over the fixes Microsoft noted in the previous build 22000.346, which included patches for many printer issues, among other things.

The official changelog for Build 22000.348 says:

We fixed a known issue that might prevent apps, such as Kaspersky apps, from opening after you attempt to repair or update the apps using the Microsoft Installer (MSI).

Kaspersky provides more information related to this issue. The firm notes:

After the installation of a Windows update Kaspersky Endpoint Security for Windows keeps functioning correctly and the security of the system remains intact. However errors may occur at attempts to upgrade the application, install a private patch or change the scope of the application components.

The firm has also given a list of updates that it thinks were the root cause for the problem on various Windows builds. For Windows 11, Kaspersky has labeled the recent Windows 11 Patch Tuesday build 22000.318 (KB5007215) as the culprit.

You can find the original press release for Build 22000.348 linked here.

Update: Added link to Kaspersky's site.

Report a problem with article
The UBports Foundation logo
Next Article

UBports releases its twentieth stable update of Ubuntu Touch

A woman on a call to a colleague
Previous Article

Microsoft to launch Teams Phone with Calling Plan for businesses in the new year

Join the conversation!

Login or Sign Up to read and post a comment.

7 Comments - Add comment